현대약품

004310KOSPIView the 제약 sectorTheme Bio & healthcare

6,850KRWMarket close of 10/27 (Tue)

Up +2.24%+150KRWMarket close of 10/27 (Tue)

Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)6,880KRWUp +0.44%

Preliminary · replaced once official KRX data for the same date is published

Open
6,760
High
7,110
Low
6,730
Day range
Day range low 6,730 high 7,110, open 6,760, close 6,850, previous close 6,700
Volume
49×10K shares
3.4B KRW 0.37× the 20-session average

Market close of 10/27 (Tue)

Where it sits in the 1-year range

1-year close range 3,545 to 14,340 won, 31% up from the low

31% of the way up from the lowest close in 1 year (252 sessions) · -52.2% from the high

Loading

Free · no sign-inSource from 2021-05-17

Data dateMost recent closing data10/27 (Tue)
Market close data of 2026-10-27

Points to check

  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 2 are within the usual range

  • Daily move+2.24%usual range
  • Trading value0.4×usual range
See the full check report

Same sector · 제약

Down -2.22%

· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW

Same sector · top by trading value
Stock20DChangeTrading value
삼성바이오로직스Close over the last 20 sessions +0.6%Down -5.37%124.5B KRW
셀트리온Close over the last 20 sessions +6.3%Down -0.74%82.4B KRW
지투지바이오Close over the last 20 sessions +22.2%Down -13.38%46.9B KRW
한미약품Close over the last 20 sessions -32.6%Down -0.57%25.5B KRW
에스티팜Close over the last 20 sessions -11.9%Down -9.15%21.4B KRW

Schedule

  • Next data 10/29 (Thu) after 08:50

Related news

All news
Loading

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.